Daniel Muscionico, PharmD, MPH, MBA
Senior Vice President, Global Operations
Daniel Muscionico is Senior Vice President of Global Operations, bringing extensive experience in managing life science companies to Alira Health. Previously, he was the Chief Operating Officer at Wellmera and a member of the Management Team prior to Alira Health’s acqusition of Wellmera in 2019.
Daniel has also served as Chief Operating Officer at a global regulatory life sciences consulting firm targeted towards biotech, medtech and pharma ventures. Daniel helped the company grow and establish its leadership within the industry thanks to optimized operations. He has been responsible for managing day-to-day international operations and overseeing HR, Finance, Corporate IT, Legal and Compliance, and Business Development.
Previously, he was CEO of the OFAC Group, a shared services company for healthcare professionals contributing to several national digital health and smart data projects. He has a particular interest in data protection and patient rights issues. His expertise encompasses management of information and health systems, GDPR / ISO 27001 certifications, and ensuring convergence of services and technology.
Being confronted daily with access and funding issues as part of his business activities, he graduated in 2005 at the Geneva School of Economics and Management earning an Executive MBA in Management Finance. His dissertation topic related to managed care and new compensation models in healthcare systems, such as capitation.
Daniel values building scalable solutions for better healthcare delivery and establishing market access conditions that saves lives.
Daniel holds a Doctor of Pharmacy from the Faculty of Pharmacy at the University of Geneva, Switzerland. He also holds an MPH Degree (Master of Public Health) from the Faculty of Medicine at the University of Geneva, Switzerland.
Currently, he is a Senior Lecturer at the Geneva University Institute of Global Health delivering courses in public health, health economics and market access to students following the Master of Pharmacy and Master of Global Health curricula.